Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Davidson

Showing results (101-110 of 999) with videos related to

Pageof 100
Sort By:
Nature|October 24, 1997
Evolutionary biology. Insights from the echinodermsE H Davidson
Ebiomedicine|July 3, 2015
Beta-2 Agonism: A Potential Therapeutic Target for DyslipidemiaMichael H Davidson
Current Atherosclerosis Reports|December 21, 2000
Does differing metabolism by cytochrome p450 have clinical importance?M H Davidson
Expert Opinion on Investigational Drugs|May 29, 2003
Rosuvastatin: a highly efficacious statin for the treatment of dyslipidaemiaMichael H Davidson
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|September 1, 1994
Molecular biology of embryonic development: how far have we come in the last ten years?E H Davidson
Expert Review of Cardiovascular Therapy|March 20, 2004
Ezetimibe: a novel option for lowering cholesterolMichael H Davidson
Current Opinion in Lipidology|May 2, 2018
Clinical trialsMichael H Davidson
Expert Opinion on Pharmacotherapy|October 13, 2007
The use of colesevelam hydrochloride in the treatment of dyslipidemia: a reviewMichael H Davidson
The American Journal of Cardiology|February 20, 2007
Global risk management in patients with type 2 diabetes mellitusMichael H Davidson
The American Journal of Managed Care|November 23, 2006
Differences between clinical trial efficacy and real-world effectivenessMichael H Davidson
Pageof 100

Showing results (101-110 of 999) with videos related to

Sort By:
Pageof 100
Nature|October 24, 1997
Evolutionary biology. Insights from the echinodermsE H Davidson
Ebiomedicine|July 3, 2015
Beta-2 Agonism: A Potential Therapeutic Target for DyslipidemiaMichael H Davidson
Current Atherosclerosis Reports|December 21, 2000
Does differing metabolism by cytochrome p450 have clinical importance?M H Davidson
Expert Opinion on Investigational Drugs|May 29, 2003
Rosuvastatin: a highly efficacious statin for the treatment of dyslipidaemiaMichael H Davidson
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|September 1, 1994
Molecular biology of embryonic development: how far have we come in the last ten years?E H Davidson
Expert Review of Cardiovascular Therapy|March 20, 2004
Ezetimibe: a novel option for lowering cholesterolMichael H Davidson
Current Opinion in Lipidology|May 2, 2018
Clinical trialsMichael H Davidson
Expert Opinion on Pharmacotherapy|October 13, 2007
The use of colesevelam hydrochloride in the treatment of dyslipidemia: a reviewMichael H Davidson
The American Journal of Cardiology|February 20, 2007
Global risk management in patients with type 2 diabetes mellitusMichael H Davidson
The American Journal of Managed Care|November 23, 2006
Differences between clinical trial efficacy and real-world effectivenessMichael H Davidson
Pageof 100